attention%20deficit_hyperactivity%20disorder
ATTENTION DEFICIT/HYPERACTIVITY DISORDER
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by the presence of impairing levels of inattention, disorganization and/or hyperactivity-impulsivity.
Symptoms that suggest ADHD include hyperactivity, acting without thinking, inattention/daydreaming, fidgety, restless, excessive talking, aggressive behavior, academic underachievement, disorganized and has difficulty in completing tasks.
  1. Ghuman JK, Arnold LE, Anthony BJ. Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice. J Child Adolesc Psychopharmacol. 2008 Oct;18(5):413-447. doi: 10.1089/cap.2008.022. PMID: 18844482
  2. Pliszka S; AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007 Jul;46(7):894-921. PMID: 17581453
  3. Millichap JG. Etiologic classification of attention-deficit/hyperactivity disorder. Pediatrics. 2008 Feb;121(2):e358-e365. doi: 10.1542/peds.2007-1332. PMID: 18245408
  4. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011 Nov;128(5):1007-1022. doi: 10.1542/peds.2011-2654. Accessed 22 Jan 2012. PMID: 22003063
  5. Smoot LC, Boothby LA, Gillett RC. Clinical assessment and treatment of ADHD in children. Int J Clin Pract. 2007 Oct;61(10):1730-1738. PMID: 17877659
  6. National Collaborating Centre for Mental Health. Diagnosis and management of ADHD in children, young people and adults. Attention Deficit Hyperactivity Disorder. London: The British Psychological Society, The Royal College of Psychiatrists; 2006
  7. MedWormhttp://www.medworm.com/rss/index.php/Pediatrics/33/http://www.medworm.com/rss/medicalfeeds/specialities/Pediatrics.xml
  8. MedWorm http://www.medworm.com/rss/index.php/Psychiatry/172/ www.medworm.com/rss/medicalfeeds/specialities/Psychiatry-News.xml
  9. ADHD: Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficity/hyperactivity disorder in children and adolescents. Process of care supplemental appendix. http://pediatrics.aappublications.org. 2011. Accessed 22 Jan 2012.
  10. Krull KR. Attention deficit hyperactivity disorder in children and adolescents: pharmacotherapy. UpToDate. http://www.uptodate.com. 06 Jan 2012. Accessed 22 Jan 2012.
  11. Krull KR. Attention deficit hyperactivity disorder in children and adolescents: clinical features and evaluation. UpToDate. http://www.uptodate.com. 06 Jan 2012. Accessed 22 Jan 2012.
  12. National Collaborating Centre for Mental Health. Attention deficity hyperactivity disorder. Diagnosis and management of ADHD in children, young people and adults. CG 72. http://guidance.nice.org.uk. Sep 2008.
  13. Krull KR. Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications. UpToDate. http://www.uptodate.com. 06 Jan 2012. Accessed 22 Jan 2012.
  14. University of Michigan Health System. Attention-deficit hyperactivity disorder. http://ocpd.med.umich.edu. Oct 2005.
  15. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). CADDRA: Canadian ADHD practice guidelines. 3rd Ed. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA). http://www.caddra.ca/. 2011.
  16. Dobie C, Donald WB, Hanson M,et al; Institute for Clinical Systems Improvement. Diagnosis and management of attention deficit hyperactivity disorder in primary care for school-age children and adolescents. ICSI. https://www.icsi.org/. Mar 2012.
  17. Cincinnati Children’s Hospital Medical Center. Evidence-based clinical practice guideline for outpatient evaluation and management of attention deficit/hyperactivity disorder. http://www.cincinnatichildrens.org. Apr 2004
  18. Institute for Clinical Systems Improvement (ICSI). Health care guideline: diagnosis and management of attention-deficit hyperactivity disorder in primary care for school age children and adolescents. ICSI. http://www.icsi.org. Jan 2005.
  19. Scottish Intercollegiate Guidelines Network. Management of attention deficity and hyperkinetic disorders in children and young people. SIGN. http://www.sign.ac.uk. 2009.
  20. National Institute for Health and Care Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. NICE. http://www.nice.org.uk. Mar 2006.
  21. American Psychiatric Association. Attention-Deficit/Hyperactivity Disorder. In: Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013:59-61.
  22. Ministry of Health Singapore. Clinical practice guidelines attention deficit hyperactivity disorder. MOH Singapore. http://www.moh.gov.sg. 2014 Jan. Accessed 22 Sep 2015.
  23. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE. https://www.nice.org.uk. 14 Mar 2018. Accessed 23 Jul 2018.
  24. Krull KR. Attention deficit hyperactivity disorder in children and adolescents: clinical features and diagnosis. UpToDate. http://www.uptodate.com. Feb 2019.
  25. French WP. Assessment and treatment of attention-deficit/hyperactivity disorder: part 1. Pediatr Ann. 2015 Mar;44(3):114-120. doi: 10.3928/00904481-20150313-13. PMID: 25806728
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 5 days ago

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

Pearl Toh, 6 days ago
Daily intake of sugar-sweetened beverages was associated with elevated triglyceride levels and lower HDL cholesterol levels, both of which are risk factors for cardiovascular disease (CVD), according to the Framingham Heart Study with up to 23 years of follow-up.
Stephen Padilla, 28 May 2020
Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.
2 days ago
Use of corticosteroid is not associated with improved outcomes in idiopathic pulmonary fibrosis (IPF) patients admitted to the hospital with acute exacerbation (AE), reveals a recent study. In addition, corticosteroids may even contribute to reduced overall survival following exacerbation.